A person’s immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.
Bausch + Lomb bulks up OTC business with J&J deal
Dive Brief: Bausch + Lomb continues to bulk up via dealmaking, announcing Thursday a deal to buy a line of eye and contact lens drops